Skip to main content
Clinical Trials/NCT01720914
NCT01720914
Completed
Not Applicable

Instruments for Delirium Assessment Regarding to Analgesia Sedation and Ventilator Status

Charite University, Berlin, Germany2 sites in 2 countries160 target enrollmentNovember 2012
ConditionsDelirium

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Delirium
Sponsor
Charite University, Berlin, Germany
Enrollment
160
Locations
2
Primary Endpoint
Sensitivity of the delirium screening/diagnosing tool "Confusion Assessment Method for the ICU (CAM-ICU)" regarding sedation and ventilator status.
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

In this prospective, multicenter observational study we assess the diagnostic validity of the following standard screening instruments for delirium regarding sedation, analgesia and ventilator status in critically ill patients:

  • Confusion Assessment Method for the ICU (CAM-ICU)
  • Intensive Care Delirium Screening Checklist (ICDSC)
  • Nursing-Delirium-Screening-Scale (Nu-DESC)

The definite delirium diagnosis (definite in terms of reference standard) is made according to the criteria of the Diagnostic and Statistical Manual of Mental Disorders 4th Edition, text revised (DSM-IV-TR) published by the American Psychiatric Association (APA) which is the Gold Standard to diagnose delirium.

Primary research question: Does sedation, ventilator status and analgesia influence the sensitivity of delirium screening tools (DST)?

Registry
clinicaltrials.gov
Start Date
November 2012
End Date
December 2015
Last Updated
10 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Claudia Spies

Department of Anesthesiology and Intensive Care Medicine CVK/CCM, Charite University, Berlin, Germany

Charite University, Berlin, Germany

Eligibility Criteria

Inclusion Criteria

  • Critically ill patient
  • Patient age \> 18 years

Exclusion Criteria

  • Neurosurgical patients
  • Severe brain injury, intracerebral bleeding, stroke
  • Inability to communicate due to anacusia or severe hearing loss
  • Insufficient language comprehension
  • Patients \< 24 h total time of Intensive Care Unit stay
  • Deep sedation (RASS \< -3) for ≥ 7 days during study participation

Outcomes

Primary Outcomes

Sensitivity of the delirium screening/diagnosing tool "Confusion Assessment Method for the ICU (CAM-ICU)" regarding sedation and ventilator status.

Time Frame: Participants will be followed in the 7-days sample period

Used reference standard: DSM-IV TR criteria

Sensitivity of the delirium-screening tool "Intensive-Care Delirium Screening Checklist(ICDSC)" regarding sedation and ventilator status.

Time Frame: Participants will be followed in the 7-days sample period

Used reference standard: DSM-IV TR criteria.

Sensitivity of the delirium screening tool "Nursing Delirium Screening Scale (Nu-DESC)" regarding sedation and ventilator status.

Time Frame: Participants will be followed in the 7-days sample period

Used reference standard: DSM-IV TR criteria

Secondary Outcomes

  • Specificity of the "Confusion Assessment Method for the ICU (CAM-ICU)", the "Intensive Care Delirium Screening Checklist (ICDSC)" and the "Nursing Delirium Screening Scale" regarding sedation and ventilator status.(Participants will be followed in the 7-days sample period)
  • Calculation and Analysis of the positive predictive values of the assessed delirium-screening scales.(Participants will be followed in the 7-days sample period)
  • Incidence of delirium(Participants will be followed in the 7-days sample period)
  • Incidence of Subsyndromale Delirium (SSD)(Participants will be followed in the 7-days sample period)
  • Analgesia(Participants will be followed in the 7-days sample period:)
  • Ventilator status(Participants will be followed in the 7-days sample period)
  • Administered neuroleptics, cumulative(Participants will be followed in the 7-days sample period)
  • Administered analgesics, cumulative(Participants will be followed in the 7-days sample period)
  • Administered sedatives, cumulative(Participants will be followed in the 7-days sample period)
  • Severity of illness(Participants will be followed in the 7-days sample period)
  • Antibiotics/infections(Participants will be followed in the 7-days sample period)
  • ICU length of stay(Participants will be followed for the duration of intensive care unit stay and hospital stay, an expected average of 4 weeks)
  • Duration of mechanical ventilation(Participants will be followed for the duration of intensive care unit stay and hospital stay, an expected average of 4 weeks)
  • Discharge mode(Participants will be followed for the duration of intensive care unit stay and hospital stay, an expected average of 4 weeks)
  • 28-day mortality(Participants will be followed for the duration of intensive care unit stay and hospital stay, an expected average of 4 weeks)
  • Specificity of the "Confusion Assessment Method for the ICU (CAM-ICU)", the "Intensive Care Delirium Screening Checklist (ICDSC)" and the "Nursing Delirium Screening Scale" regarding analgesia.(Participants will be followed in the 7-days sample period)
  • Sensitivity of the "Confusion Assessment Method for the ICU (CAM-ICU)", the "Intensive Care Delirium Screening Checklist (ICDSC)" and the "Nursing Delirium Screening Scale" regarding analgesia.(Participants will be followed in the 7-days sample period)

Study Sites (2)

Loading locations...

Similar Trials